Acute Myocardial Infarction with Severe ST Segment Elevation Treated with Percutaneous Coronary Intervention More than Two Days after Onset: A Case with Remarkable Recovery

 

 Buy Article Permissions and Reprints

ABSTRACT

The patient was a 65-year-old man with marked ST-elevation myocardial infarction. Cardiac catheterization revealed an occluded middle portion of the left anterior descending artery and no collateral circulation. Percutaneous coronary intervention (PCI) was performed, and ST elevation improved 5 days after PCI. Almost all electrocardiogram (ECG) findings were normal 6 months later. Echocardiographic findings were also normal. This case was very successful and unusual in that no ventricular aneurysm formed despite ST elevation continuing for a few days and that ECG and left ventricular function were nearly normal after PCI performed days after the onset in a case without collateral circulation.

REFERENCES

• 1 Murry C E, Jennings R B, Reimer K A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.  Circulation. 1986;  74 1124-1136
  CrossrefPubMedGoogle Scholar
• 2 Ishihara M, Sato H, Tateishi H et al.. Implications of prodromal angina pectoris in anterior wall acute myocardial infarction: acute angiographic findings and long-term prognosis.  J Am Coll Cardiol. 1997;  30 970-975
  CrossrefPubMedGoogle Scholar
• 3 Ishihara M, Inoue I, Kawagoe T et al.. Effect of prodromal angina pectoris on altering the relation between time to reperfusion and outcomes after a first anterior wall acute myocardial infarction.  Am J Cardiol. 2003;  91 128-132
  CrossrefPubMedGoogle Scholar
• 4 Yellon D M, Hausenloy D J. Myocardial reperfusion injury.  N Engl J Med. 2007;  357 1121-1135
  CrossrefPubMedGoogle Scholar
• 5 Hausenloy D J, Yellon D M. Time to take myocardial reperfusion injury seriously.  N Engl J Med. 2008;  359 518-520
  CrossrefPubMedGoogle Scholar
• 6 van 't Hof A W, Liem A, Suryapranata H, Hoorntje J C, de Boer M J, Zijlstra F. Zwolle Myocardial Infarction Study Group . Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade.  Circulation. 1998;  97 2302-2306
  CrossrefPubMedGoogle Scholar
• 7 Takano M, Mizuno K, Yokoyama S et al.. Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy.  J Am Coll Cardiol. 2003;  42 680-686
  CrossrefPubMedGoogle Scholar
• 8 Nissen S E, Tuzcu E M, Schoenhagen P REVERSAL Investigators et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.  JAMA. 2004;  291 1071-1080
  CrossrefPubMedGoogle Scholar
• 9 Schartl M, Bocksch W, Koschyk D H et al.. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease.  Circulation. 2001;  104 387-392
  CrossrefPubMedGoogle Scholar
• 10 Uehara M, Funabashi N, Mikami Y, Shiina Y, Nakamura K, Komuro I. Quantitative effect of atorvastatin on size and content of non-calcified plaques of coronary arteries 1 year after atorvastatin treatment by multislice computed tomography.  Int J Cardiol. 2008;  130 269-275
  CrossrefPubMedGoogle Scholar
• 11 First International Study of Infarct Survival Collaborative Group . Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1.  Lancet. 1986;  2 57-66
  PubMedGoogle Scholar
• 12 Cannon C P, Braunwald E, McCabe C H Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.  N Engl J Med. 2004;  350 1495-1504
  CrossrefPubMedGoogle Scholar
• 13 Schwartz G G, Olsson A G, Ezekowitz M D Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.  JAMA. 2001;  285 1711-1718
  CrossrefPubMedGoogle Scholar
• 14 Okazaki S, Yokoyama T, Miyauchi K et al.. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.  Circulation. 2004;  110 1061-1068
  CrossrefPubMedGoogle Scholar
• 15 Patti G, Pasceri V, Colonna G et al.. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.  J Am Coll Cardiol. 2007;  49 1272-1278
  CrossrefPubMedGoogle Scholar
• 16 Birnbaum Y, Ashitkov T, Uretsky B F, Ballinger S, Motamedi M. Reduction of infarct size by short-term pretreatment with atorvastatin.  Cardiovasc Drugs Ther. 2003;  17 25-30
  CrossrefPubMedGoogle Scholar

Michiyoshi SoneM.D. 

Department of Cardiology, Koto Hospital

6-8-5 Ojima Koto-ku, Tokyo 136-0072, Japan

Email: kmws862170@yahoo.co.jp